pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
fda medwatch·Aug 13·1 min read
save

Baxter recalls Duo-Vent IV solution sets over risk of air bubbles in patients

Aug 13, 2026·read at fda medwatch ↗CRLNegative

Baxter has issued a recall of its Duo-Vent solution sets and male Luer lock adapters after the FDA identified a risk that the devices could contain air bubbles in the drip chamber and tubing.

The presence of air bubbles could allow air to be delivered through the IV line to patients, which the FDA classifies as a Class I recall, the most serious type, because it may cause serious injury or death.

Baxter sent a letter to customers on June 30 advising them to immediately locate, isolate, and stop using the affected lot numbers (DR26C27062, DR26D14031, DR26E1305500085412014319), and to return the products for replacement.

Facilities are instructed to quarantine the devices, contact Baxter Healthcare Center for service, and inform relevant staff such as directors of nursing, pharmacy, purchasing, and risk management.

source

This writeup was produced by pharmadog from original reporting by fda medwatch.

Original headline: “Intravascular Administration Set Recall: Baxter Removes Duo-Vent Solution Sets”

read at fda medwatch ↗
622 words · retrieved Aug 13
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Baxter Healthcare Corp2UNIQUE
topics
Recall10

related stories

  • Jul 20Early Alert: Intravascular Administration Set Issue from Baxterfda medwatch
  • Aug 10Catheter Introducer Correction: Abiomed and Oscor Issue Correction for Catheter Introducerfda medwatch
  • Aug 4Early Alert: Intraosseous Needle Set Issue from Becton Dickinsonfda medwatch
  • Aug 3Convenience Kit Correction: Medical Action Industries Issues Correction for Kits Containing Recalled Namic Manifoldsfda medwatch
  • Aug 3Convenience Kit Correction: Medline Issues Correction for Kits Containing Huons Lidocaine Hydrochloride and Bupivacaine Hydrochloride in Dextrose Injectionfda medwatch